Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,586 | -5,087 | -6,313 | -6,728 | -3,265 |
| Accounts payable and accrued liabilities | -74 | -74 | 2 | 36 | 47 |
| Other Working Capital | -75 | -48 | 155 | -13 | -118 |
| Other Operating Activity | 570 | 916 | 1,544 | 2,563 | 1,205 |
| Operating Cash Flow | $-3,165 | $-4,293 | $-4,612 | $-4,143 | $-2,131 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 3,143 | 5,141 | 3,908 | 4,602 |
| Other Financing Activity | 0 | 0 | 0 | -11 | 0 |
| Financing Cash Flow | $N/A | $3,143 | $5,141 | $3,897 | $4,602 |
| Beginning Cash Position | 4,204 | 5,353 | 4,824 | 5,069 | 2,599 |
| End Cash Position | 1,039 | 4,204 | 5,353 | 4,824 | 5,069 |
| Net Cash Flow | $-3,165 | $-1,150 | $530 | $-246 | $2,470 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,165 | -4,293 | -4,612 | -4,143 | -2,131 |
| Free Cash Flow | -3,165 | -4,293 | -4,612 | -4,143 | -2,131 |